. . . . . . . . . . . "a(CHEBI:erlotinib) -| bp(GOBP:\"cell cycle\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Growth of HBECs was highly dependent on epidermal growth factor (EGF) and completely inhibited by EGF receptor (EGFR) tyrosine kinase inhibitors, which induced G1 arrest from full text - EGFR inhibitors used were gefitinib and erlotinib" . . "Selventa" . . . . "2014-07-03T14:32:56.439+02:00"^^ . . .